This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
On October 5, 2021, Drug Channels Institute will release The 2021–22 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. pharmaceutical distribution industry. Those who preorder will receive a download link before October 5. CLICK HERE to download a free pre-publication draft overview. to 1:30 p.m.
Cookieless Marketing of Pharmaceuticals Requires Real-World Data Pharma ads face uncertainty with fading third-party cookies. Adapting to cookieless marketing means integrating real-world data into all campaign phases, demanding close collaboration and reliance on new data sources for effective targeting. Download now.
Innovations in Analytical Testing, Biopharma, and Manufacturing Access our report today for a deep dive into the critical advancements shaping the future of pharmaceutical development. Discover how to ensure drugs meet the highest standards before they reach the market.
I am pleased to announce our new 2021–22 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , available for purchase and immediate download. pharmaceutical distribution industry. reviews AmerisourceBergen’s entry into the European distribution market. (We Section 7.4.4. Section 6.1.5.
I am pleased to announce our new 2022–23 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , available for purchase and immediate download. Click here to download a free report overview (including a summary of industry trends, the Table of Contents, and a List of Exhibits) New Drug Channels Institute Study: U.S.
Pharmacies and Pharmacy Benefit Managers , available for purchase and immediate download. Click here to download a free report overview (including key industry trends, the Table of Contents, and a List of Exhibits) New Drug Channels Institute Study Examines Consolidation and Vertical Integration of U.S. Click to Enlarge].
Stop running in circles—It’s time to unlock proven strategies to propel market access. A program driven by market dynamics and led by champions of channel strategy, join your peers now to master the complexities of pharmacy and distribution models to accelerate market access—It's all happening December 10-12.
and Aavis Pharmaceuticals Inc. “We are pleased to announce the commercial launch of Hydroxychloroquine Sulfate tablets in the U.S.through our marketing partner,” stated Ashok Barot , Chairman, Aavis Pharmaceuticals. D/B/A Aavis Pharmaceuticals. About Senores Pharmaceuticals Pvt. YARDLEY, Pa.
If you're a pharmaceutical researcher or drug developer, understanding these breakthroughs is critical to staying at the forefront of innovation. Addressing Industry Challenges We then dig into the broader challenges the pharmaceutical industry is facing in drug discovery and development.
A program driven by market dynamics and led by champions of channel strategy, join now to master the complexities of pharmacy and distribution models to accelerate market access –It's all happening December 11-13, 2023. Why should you attend this pivotal event? How is health policy affecting the distribution channel?
WHAT YOU WILL LEARN As expensive specialty therapies come to dominate drug spending, pharmaceutical manufacturers are paying a growing share of patents’ out-of-pocket costs for these prescriptions. Or, download this spreadsheet and email your registrants’ information to Tamra Feldman ( admin@drugchannels.net ).
On October 10, 2023, Drug Channels Institute will release 2023-24 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. pharmaceutical distribution industry. Those who preorder will receive a download link before October 10. Download a free report overview for more details on the new sections and content.
Addressing these underlying factors is essential; only by tackling the complexities of recruitment, timelines and regulatory compliance can sponsors achieve cost-effective and efficient trials, paving the way for long-term success in todays demanding market. With trials facing a median delay of 12.2
Emily Phillips, Reimbursement, Patient Advocate, & Government Affairs Leader Melissa Beatty, Director, Patient Services and Reimbursement, CTI Bio Pharma Chad Bower, Executive Director, Field Reimbursement & Oncology Solutions, US Market Access, Daiichi Sankyo, Inc. Download the full agenda and save your seat today!
The PPD clinical research business of Thermo Fisher Scientific conducts an annual survey of more than 150 leaders at pharmaceutical companies around the globe to assess trends in drug discovery and development, including preferences around outsourcing and functional service provider (FSP) utilization.
20, 2020 /PRNewswire/ — CNS PHARMACEUTICALS AG , Inc. manufacturer, Pharmaceutics International, Inc. (“Pii”), has completed the manufacturing process for Berubicin Drug Product, its lead drug candidate for the treatment of glioblastoma multiforme (GBM), an aggressive form of brain cancer currently considered incurable.
…
Biopharmaceutical products represent up to 20 percent of the total pharmaceuticalmarket and are growing at a rate of nearly eight percent annually.
DOWNLOAD TO LEARN MORE>>>> Source link.
DOWNLOAD TO LEARN MORE>>>> Source link.
.
27, 2020 /PRNewswire/ — Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced that the company has submitted an application for market approval for the drug candidate Sedaconda (isoflurane), formerly known as IsoConDa, for inhaled sedation in intensive care.
STOCKHOLM , Nov.
Download Your Copy.
We respect your privacy, by clicking “Download Your Copy” you will receive our e-newsletter, including information on Podcasts, Webinars, event discounts,
online learning opportunities and agree to our User Agreement.
Download Your Copy.
Download Your Copy.
27, 2020 /PRNewswire/ — Aridis Pharmaceuticals, Inc. Dr. Hasan Jafri , Chief Medical Officer of Aridis Pharmaceuticals, will be a speaker on a panel entitled “Direct Antivirals and Other Agents Against SARS-CoV2 Virus.” About Aridis Pharmaceuticals, Inc. Aridis Pharmaceuticals, Inc. SAN JOSE, Calif. ,
Drug Channels readers are eligible for an exclusive savings of 10% off * the standard rate by using promo code 23DC10 , so download the complete conference agenda and reserve your seat today! Benefit from a fireside chat, in-depth sessions and learning streams, plus additional networking opportunities!
However, as the world settles into its post-pandemic state and returns to pre-pandemic paradigms in many areas, the pharmaceutical industry remains dedicated to moving beyond traditional, centralized clinical trial constructs. Study sponsors need quality results as quickly as possible to maximize profit-generation opportunities in the market.
28, 2021 /PRNewswire/ — CASI Pharmaceuticals (Formerly Known As EntreMed, Inc.).
About CASI Pharmaceuticals.
CASI Pharmaceuticals, Inc. The Company’s operations in China are conducted through its wholly-owned subsidiary, CASI Pharmaceuticals ( China ) Co., and BEIJING , Jan.
The pharmaceutical product landscape is rapidly and fundamentally changing with profound impact on research and development strategy and technology needs.
DOWNLOAD TO LEARN MORE>>>> Source link.
27, 2021 /PRNewswire/ — Armata Pharmaceuticals , Inc.
About Armata Pharmaceuticals, Inc.
Media Contacts:
At Armata:
Steve Martin
Armata Pharmaceuticals, Inc.
View original content to download multimedia: [link].
.
15, 2020 /PRNewswire/ — Armata Pharmaceuticals , Inc. Patrick , Chief Executive Officer of Armata Pharmaceuticals.
About Armata Pharmaceuticals, Inc.
Media Contacts:
At Armata:
Steve Martin
Armata Pharmaceuticals, Inc.
.
.
“Receiving Fast Track designation is an important acknowledgment of the results of our COVID-19 laboratory research,” commented Leo Ehrlich, Chief Executive Officer at Innovation Pharmaceuticals. A preprint supporting Brilacidin’s COVID-19 treatment potential can be downloaded at the link below.
Source link.
When working on drug discovery projects, it's handy to have access to a set of chemical structures and associated data for marketed drugs. If you're considering introducing new functionality, someone invariably asks whether that functionality has been used in a marketed drug. Download the ChEMBL database.
–( BUSINESS WIRE )– Concert Pharmaceuticals, Inc. President and Chief Executive Officer of Concert Pharmaceuticals. Please log on to the Concert website approximately 15 minutes prior to the scheduled webcast to ensure adequate time for any software downloads that may be required. 5, 2020 11:00 UTC. LEXINGTON, Mass.–(
Maypharm is focusing on outstanding pharmaceutical products to provide superior botulinum toxin product with an up-to-date technological advantage and elaborated advanced manufacturing quality system and sophisticated equipment to meet the GMP requirements of the Agency’s CGMP regulations. For more information visit www.maypharm.net.
Download the brochure. The Healthcare Innovation Company's Value-Based Care Summit In-Person Event | October 28 - 29, 2024 in Washington, DC Use promo code VBCDC to save $100. Register Today.
NYSE: LCI) today announced that it will report financial results for its fiscal 2021 first quarter on Wednesday, November 4, 2020 , after the market closes. Listeners are encouraged to visit the website at least 10 minutes prior to the start of the scheduled presentation to register, download and install any necessary audio software.
subsidiary of Santen Pharmaceutical Co.,
About Santen
As a specialized company dedicated to ophthalmology, Santen carries out research, development, marketing, and sales of pharmaceuticals, over-the-counter products, and medical devices.
View original content to download multimedia: [link].
Due to open source data’s accessibility, it is an appealing resource for drug research as it often enables cost-effective sources for emerging pharmaceutical companies and academic research projects. This can be made more complex when trying to navigate your team’s unique research focus against an ever expanding market.
A cornerstone of digital transformation, these solutions are accelerating the transition to Pharma 4.0 – a future vision of the pharmaceutical industry characterized by smart production workflows, flexible value chains and real-time process optimization.
Drug Channels readers are eligible for an exclusive savings of 10% off * the standard rate by using promo code 21CCCDC10 , so download the complete conference agenda and reserve your seat today! Expires 6/25/20210; applies to standard rate only and may not be combined or applied to existing registrations; other restrictions may apply.
The PPD clinical research business of Thermo Fisher Scientific has surveyed more than 150 drug developers around the globe to gather annual data on trends in pharmaceutical research and development. Successful market access and product update stems from valuable RWD and RWE regarding a product’s safety, effectiveness and value.
The PPD clinical research business of Thermo Fisher Scientific has surveyed more than 150 drug developers around the globe to gather annual data on trends in pharmaceutical research and development. DOWNLOAD THE FULL REPORT The post Survey Uncovers Global Challenges and Opportunities in Drug Development appeared first on PPD Inc.
ASP5354 is an investigational compound discovered by Mie University and Nagoya University, with Astellas acquiring exclusive development and marketing rights worldwide.
is a pharmaceutical company conducting business in more than 70 countries around the world.
For more information, please visit [link].
You can download the complete agenda here. Download the agenda to plan your sessions and wrap up your week armed with critical updates and valuable takeaways. Visit www.informaconnect.com/gtn for further details and to register.
Worldwide Clinical Trials recently conducted a comprehensive research study, where we included 140 key industry-decision makers from biotech and pharmaceutical companies of all sizes. The Advantages of Midsize CROs In contrast to large CROs, midsize CROs like Worldwide Clinical Trials offer a unique value proposition to the market.
Case Study: Innovative Nanosuspension Approach to Maximize API Potency in Preclinical Formulation Development aasimakopoulos Thu, 09/12/2024 - 20:51 Download a copy of this case study.
Quantitative imaging of CD8 T cells enables quicker identification of drug efficacy, therefore potentially reducing the length of clinical trials, reducing costs and helping new therapies to advance to market faster, which ultimately will improve treatment and care of cancer patients. View original content to download multimedia: [link].
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content